Genomtec (WAR:GMT) FCF Margin %: -11,668.75% (As of Mar. 2026)


WAR:GMT Genomtec SA WAR:GMT
26 GF Score
Price zł4.78
! 3 Warning Signs
View Full Analysis

What is Genomtec FCF Margin %?

Genomtec WAR:GMT +1.49% 26 FCF Margin % is -11,668.75% as of Mar. 2026. GuruFocus rates WAR:GMT with a GF Score™ of 26/100. The stock has 3 warning signs investors should review. Among 815 Medical Devices & Instruments companies, Genomtec ranks worse than 99.39% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Genomtec's Free Cash Flow for the three months ended in Mar. 2026 was zł-1.87 Mil. Genomtec's Revenue for the three months ended in Mar. 2026 was zł0.02 Mil. Therefore, Genomtec's FCF Margin % for the quarter that ended in Mar. 2026 was -11,668.75%.

As of today, Genomtec's current FCF Yield % is -10.04%.

The historical rank and industry rank for Genomtec's FCF Margin % or its related term are showing as below:

WAR:GMT' s FCF Margin % Range Over the Past 10 Years
Min: -1147900   Med: -16478.75   Max: -2096.08
Current: -30293.75

During the past 8 years, the highest FCF Margin % of Genomtec was -2096.08%. The lowest was -1147900.00%. And the median was -16478.75%.

WAR:GMT's FCF Margin % is ranked worse than
99.39% of 815 companies
in the Medical Devices & Instruments industry
Industry Median: -0.1 vs WAR:GMT: -30293.75

Genomtec FCF Margin % Related Terms

Genomtec FCF Margin % Historical Data

* Premium members only.

The historical data trend for Genomtec's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Genomtec FCF Margin % Chart

Genomtec Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Margin %
Get a 7-Day Free Trial -2,608.68 -19,822.50 -1,147,900.00 -677,500.00 -53,695.24

Genomtec Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -67,140.00 -52,866.67 -54,900.00 -40,983.33 -11,668.75

WAR:GMT vs ABT, SYK, MDT: FCF Margin % Comparison

For the Medical Devices subindustry, Genomtec's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Genomtec FCF Margin % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Genomtec's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Genomtec's FCF Margin % falls into.


WAR:GMT
26GF Score
Genomtec SA WAR:GMT
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Genomtec FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Genomtec's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-11.276/0.021
=-53,695.24 %

Genomtec's FCF Margin for the quarter that ended in Mar. 2026 is calculated as

FCF Margin=Free Cash Flow (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-1.867/0.016
=-11,668.75 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of -11,668.75% mean?
Genomtec (WAR:GMT) has a FCF Margin % of -11,668.75% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Genomtec and its competitors. According to the industry distribution chart, Genomtec ranks #810 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 99.4%.
Is Genomtec's FCF Margin % too high?
Genomtec's current FCF Margin % is -11,668.75%. Based on the distribution chart, Genomtec ranks #810 out of 815 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Genomtec has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does Genomtec's FCF Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Genomtec ranks #810 out of 815 companies for FCF Margin %. This places Genomtec in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Genomtec and its competitors. Genomtec's current FCF Margin % is -11,668.75%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Genomtec stock overvalued right now?
Genomtec (WAR:GMT) has a current FCF Margin % of -11,668.75%. The current FCF Margin % is -11,668.75%. Genomtec's overall GF Score™ is 26/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Genomtec (WAR:GMT), the current FCF Margin % is -11,668.75% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Genomtec Business Description

Other Exchanges 4VI:Germany
Address ul. Stablowicka 147, PORT Building 2, Wroclaw, POL, 54-066
Genomtec SA is an technology company which works in the area of ?? molecular diagnostics. It is a manufacturer of mobile molecular analyzers. The device are designed to identify pathogens including viruses, bacteria, and fungi by amplifying and detecting specific DNA and RNA fragments.
26GF Score

Get the complete analysis for WAR:GMT

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł4.78
Price